MindMed
Kenneth Alper is a Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine, where he completed his psychiatry residency and fellowship. Dr. Alper has investigated ibogaine and its structural derivatives from the methodological perspectives of medical ethnography, forensic and cardiovascular toxicology, and experimental pharmacology. Dr. Alper’s principal mentor in the field is Dr. Stanley Glick, with whom he coauthored and edited the only English language text on ibogaine, and they are presently the two most frequently cited authors in the field.
This person is not in the org chart
This person is not in any offices
MindMed
5 followers
MindMed is a psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness.